| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |